|
Market Closed -
Nasdaq
04:00:00 30/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 56.49 USD | -1.40% |
|
+41.22% | +83.41% |
| 10-29 | Deutsche Bank raises price target for Genmab to DKK 4,000 (3,500), reiterates buy - BN | FW |
| 10-29 | AlphaValue/Baader Europe Downgrades Genmab to Sell | MT |
Company Valuation: Genmab A/S
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 172,063 | 192,229 | 140,770 | 94,810 | 124,862 | 226,349 | - | - |
| Change | - | 11.72% | -26.77% | -32.65% | 31.7% | 81.28% | - | - |
| Enterprise Value (EV) 1 | 152,725 | 169,905 | 112,635 | 73,709 | 114,029 | 245,978 | 237,724 | 225,178 |
| Change | - | 11.25% | -33.71% | -34.56% | 54.7% | 115.72% | -3.36% | -5.28% |
| P/E | 57.8x | 35.2x | 32.6x | 12.3x | 20.9x | 46x | 31.3x | 19.6x |
| PBR | 7.82x | 7.07x | 4.5x | 2.68x | 3.47x | 5.44x | 4.62x | 3.79x |
| PEG | - | 0.4x | -1.5x | 0.1x | -1x | -3x | 0.7x | 0.3x |
| Capitalization / Revenue | 20.3x | 13.2x | 8.54x | 4.4x | 5.31x | 7.51x | 6.24x | 4.81x |
| EV / Revenue | 18x | 11.6x | 6.84x | 3.42x | 4.85x | 8.16x | 6.55x | 4.79x |
| EV / EBITDA | 46.8x | 25.3x | 20.1x | 10.4x | 15.9x | 27.3x | 18.8x | 12.2x |
| EV / EBIT | 50.6x | 26.7x | 21.2x | 10.5x | 17x | 30.2x | 21.6x | 14x |
| EV / FCF | 77.3x | 47.3x | 16.1x | 9.72x | 15.7x | 40.3x | 30.2x | 17.5x |
| FCF Yield | 1.29% | 2.12% | 6.23% | 10.3% | 6.36% | 2.48% | 3.31% | 5.7% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 45.54 | 83.65 | 66.02 | 121.4 | 97.08 | 82.26 | 120.9 | 193.1 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 8,482 | 14,595 | 16,474 | 21,526 | 23,497 | 30,150 | 36,290 | 47,019 |
| EBITDA 1 | 3,266 | 6,719 | 5,616 | 7,116 | 7,175 | 9,001 | 12,624 | 18,451 |
| EBIT 1 | 3,018 | 6,357 | 5,321 | 7,003 | 6,727 | 8,143 | 10,989 | 16,044 |
| Net income 1 | 3,008 | 5,522 | 4,352 | 7,844 | 6,083 | 5,168 | 7,799 | 12,132 |
| Net Debt 1 | -19,338 | -22,324 | -28,135 | -21,101 | -10,833 | 19,630 | 11,376 | -1,171 |
| Reference price 2 | 2,630.00 | 2,941.00 | 2,155.00 | 1,492.50 | 2,027.00 | 3,788.00 | 3,788.00 | 3,788.00 |
| Nbr of stocks (in thousands) | 65,423 | 65,362 | 65,322 | 63,524 | 61,599 | 59,754 | - | - |
| Announcement Date | 16/2/22 | 22/2/23 | 14/2/24 | 12/2/25 | 17/2/26 | - | - | - |
1DKK in Million2DKK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 16.92x | 6.39x | 12.26x | 1.77% | 64.14B | |
| 30.57x | 8.11x | 26.59x | 0.05% | 55.53B | |
| 36.68x | 6.52x | 19.45x | 0.88% | 53.03B | |
| 35.39x | 3.41x | 14.74x | -.--% | 45.99B | |
| 49.25x | 5.68x | 31.09x | -.--% | 42.45B | |
| -19.59x | 189.6x | -20.86x | -.--% | 40.45B | |
| 31.7x | 8.06x | 20.96x | 0.41% | 32.25B | |
| 47.12x | 8.37x | 28.08x | -.--% | 34.47B | |
| 27.96x | 5.9x | 15.29x | -.--% | 24.23B | |
| Average | 28.44x | 26.89x | 16.40x | 0.34% | 43.62B | |
| Weighted average by Cap. | 27.96x | 25.38x | 16.46x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Valuation Genmab A/S
Select your edition
All financial news and data tailored to specific country editions
